<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37457578</PMID><DateRevised><Year>2023</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2296-858X</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in medicine</Title><ISOAbbreviation>Front Med (Lausanne)</ISOAbbreviation></Journal><ArticleTitle>Fatigue presentation, severity, and related outcomes in a prospective cohort following post-COVID-19 hospitalization in British Columbia, Canada.</ArticleTitle><Pagination><StartPage>1179783</StartPage><MedlinePgn>1179783</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1179783</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fmed.2023.1179783</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="UNASSIGNED">Increasing evidence on long-term health outcomes following SARS CoV-2 infection shows post-viral symptoms can persist for months. These symptoms are often consistent with those of Myalgic Encephalomyelitis or Chronic Fatigue Syndrome (ME/CFS). The aim of the present study was to examine the prevalence and outcome predictors of post-viral fatigue and related symptoms 3- and 6-months following symptom onset.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">A prospective cohort of patients hospitalized with Coronavirus disease (COVID-19) (<i>n</i>&#x2009;=&#x2009;88) were recruited from a Post-COVID-19 Respiratory Clinic (PCRC) in Vancouver, Canada to examine predictors of long-term fatigue and substantial fatigue. Multivariable mixed effects analyses examined the relationship between patient predictors, including pre-existing comorbidities, patient reported outcome measures, and fatigue and substantial fatigue at follow-up.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">The number of patients experiencing fatigue or substantial fatigue at 3 months post-infection were 58 (67%) and 14 (16%) respectively. At 6 months these numbers declined to 47 (60%) patients experiencing fatigue and 6 (6%) experiencing substantial fatigue. Adjusted analysis, for sex, age, and time, revealed the number of pre-existing comorbidities to be associated with fatigue (OR 2.21; 95% CI 1.09-4.49; 0.028) and substantial fatigue (OR 1.73; 95% CI 1.06-2.95; 0.033) at 3&#x2009;months follow-up. Except for shortness of breath, self-care, and follow-up time, all follow-up variables were found to be associated with fatigue and substantial fatigue at 3 months.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Fatigue and substantial fatigue are common after COVID-19 infection but often diminish over time. A significant number of patients continue to exhibit long-term fatigue at 6&#x2009;months follow-up. Further research is needed to clarify the causality of viral infections in the development and severity of fatigue as a symptom and in meeting post-viral fatigue syndrome or ME/CFS diagnostic criteria.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Magel, Meagher, Boulter, Albert, Tsai, Mu&#xf1;oz, Carlsten, Johnston, Wong, Shah, Ryerson, Mckay and Nacul.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Magel</LastName><ForeName>Tianna</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Women's Health Research Institute, British Columbia Women's Hospital, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meagher</LastName><ForeName>Emily</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Women's Health Research Institute, British Columbia Women's Hospital, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boulter</LastName><ForeName>Travis</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Women's Health Research Institute, British Columbia Women's Hospital, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Albert</LastName><ForeName>Arianne</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Women's Health Research Institute, British Columbia Women's Hospital, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsai</LastName><ForeName>Melody</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Women's Health Research Institute, British Columbia Women's Hospital, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mu&#xf1;oz</LastName><ForeName>Carola</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Women's Health Research Institute, British Columbia Women's Hospital, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carlsten</LastName><ForeName>Chris</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Division of Respiratory Medicine, Department of Medicine, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johnston</LastName><ForeName>James</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Respiratory Medicine, Department of Medicine, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>Alyson W</ForeName><Initials>AW</Initials><AffiliationInfo><Affiliation>Division of Respiratory Medicine, Department of Medicine, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Aditi</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Respiratory Medicine, Department of Medicine, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryerson</LastName><ForeName>Chris</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Division of Respiratory Medicine, Department of Medicine, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mckay</LastName><ForeName>Rhonda Jane</ForeName><Initials>RJ</Initials><AffiliationInfo><Affiliation>General Internal Medicine, Department of Medicine, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nacul</LastName><ForeName>Luis</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Women's Health Research Institute, British Columbia Women's Hospital, Vancouver, BC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Family Practice, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CureME, London School of Hygiene and Tropical Medicine, London, United Kingdom.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Med (Lausanne)</MedlineTA><NlmUniqueID>101648047</NlmUniqueID><ISSNLinking>2296-858X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Long-COVID</Keyword><Keyword MajorTopicYN="N">chronic fatigue syndrome</Keyword><Keyword MajorTopicYN="N">myalgic encephalomyelitis</Keyword><Keyword MajorTopicYN="N">post-COVID fatigue</Keyword><Keyword MajorTopicYN="N">post-COVID fatigue syndrome</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>17</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>17</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>17</Day><Hour>4</Hour><Minute>40</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>6</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37457578</ArticleId><ArticleId IdType="pmc">PMC10344448</ArticleId><ArticleId IdType="doi">10.3389/fmed.2023.1179783</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization . WHO coronavirus (COVID-19) dashboard. (2023). Available at: https://covid19.who.int/ (Accessed February 23, 2023).</Citation></Reference><Reference><Citation>Komaroff AL, Lipkin WI. Insights from myalgic encephalomyelitis/chronic fatigue syndrome may help unravel the pathogenesis of postacute COVID-19 syndrome. Trends Mol Med. (2021) 27:895&#x2013;906. doi: 10.1016/j.molmed.2021.06.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2021.06.002</ArticleId><ArticleId IdType="pmc">PMC8180841</ArticleId><ArticleId IdType="pubmed">34175230</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban F, Ling S, Lui LMW, Lee Y, Gill H, Teopiz KM, et al. . Fatigue and cognitive impairment in post-COVID-19 syndrome: a systematic review and meta-analysis. Brain Behav Immun. (2022) 101:93&#x2013;135. doi: 10.1016/j.bbi.2021.12.020, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.12.020</ArticleId><ArticleId IdType="pmc">PMC8715665</ArticleId><ArticleId IdType="pubmed">34973396</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Q, Zheng B, Daines L, Sheikh A. Long-term sequelae of COVID-19: a systematic review and meta-analysis of one-year follow-up studies on post-COVID symptoms. Pathogens. (2022) 11:269. doi: 10.3390/pathogens11020269</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens11020269</ArticleId><ArticleId IdType="pmc">PMC8875269</ArticleId><ArticleId IdType="pubmed">35215212</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez-Ramirez DC, Normand K, Yang Z, Torres-Castro R. Long-term impact of COVID-19: a systematic review of the literature and meta-analysis. Biomedicines. (2021) 9:900. doi: 10.3390/biomedicines9080900</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9080900</ArticleId><ArticleId IdType="pmc">PMC8389585</ArticleId><ArticleId IdType="pubmed">34440104</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarrott B, Head R, Pringle KG, Lumbers ER, Martin JH. &#x201c;LONG COVID&#x201d;&#x2014;a hypothesis for understanding the biological basis and pharmacological treatment strategy. Pharmacol Res Perspect. (2022) 10:e00911. doi: 10.1002/prp2.911</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/prp2.911</ArticleId><ArticleId IdType="pmc">PMC8929332</ArticleId><ArticleId IdType="pubmed">35029046</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health and Care Excellence . Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management. (2021). Available at: https://www.nice.org.uk/guidance/ng206 (Accessed February 22, 2023)</Citation><ArticleIdList><ArticleId IdType="pubmed">35438861</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention . Long COVID or post-COVID conditions. (2022). Available at: https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html#:~:text=Estimates%20of%20the%20proportion%20of,among%20patients%20who%20were%20hospitalized (Accessed February 22, 2023)</Citation></Reference><Reference><Citation>Zaim S, Chong JH, Sankaranarayanan V, Harky A. COVID-19 and multiorgan response. Curr Probl Cardiol. (2020) 45:100618. doi: 10.1016/j.cpcardiol.2020.100618</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cpcardiol.2020.100618</ArticleId><ArticleId IdType="pmc">PMC7187881</ArticleId><ArticleId IdType="pubmed">32439197</ArticleId></ArticleIdList></Reference><Reference><Citation>Premraj L, Kannapadi N, Briggs J, Seal SM, Battaglini D, Fanning J, et al. . Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: a meta-analysis. J Neurol Sci. (2022) 434:120162. doi: 10.1016/j.jns.2022.120162, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2022.120162</ArticleId><ArticleId IdType="pmc">PMC8798975</ArticleId><ArticleId IdType="pubmed">35121209</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladds E, Rushforth A, Wieringa S, Taylor S, Rayner C, Husain L, et al. . Persistent symptoms after Covid-19: qualitative study of 114 &#x201c;long Covid&#x201d; patients and draft quality principles for services. BMC Health Serv Res [Internet]. (2020) 20:1144. doi: 10.1186/s12913-020-06001-y, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12913-020-06001-y</ArticleId><ArticleId IdType="pmc">PMC7750006</ArticleId><ArticleId IdType="pubmed">33342437</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandler CX, Wyller VBB, Moss-Morris R, Buchwald D, Crawley E, Hautvast J, et al. . Long COVID and post-infective fatigue syndrome: a review. Open Forum Infect Dis. (2021) 8:ofab440. doi: 10.1093/ofid/ofab440, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofab440</ArticleId><ArticleId IdType="pmc">PMC8496765</ArticleId><ArticleId IdType="pubmed">34631916</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah AS, Ryu MH, Hague CJ, Murphy DT, Johnston JC, Ryerson CJ, et al. . Changes in pulmonary function and patient-reported outcomes during COVID-19 recovery: a longitudinal, prospective cohort study. ERJ Open Res. (2021) 7:00243-2021. doi: 10.1183/23120541.00243-2021</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00243-2021</ArticleId><ArticleId IdType="pmc">PMC8310958</ArticleId><ArticleId IdType="pubmed">34522693</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong AW, Shah AS, Johnston JC, Carlsten C, Ryerson CJ. Patient-reported outcome measures after COVID-19: a prospective cohort study. Eur Respir J. (2020) 56:2003276. doi: 10.1183/13993003.03276-2020, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.03276-2020</ArticleId><ArticleId IdType="pmc">PMC7530908</ArticleId><ArticleId IdType="pubmed">33008936</ArticleId></ArticleIdList></Reference><Reference><Citation>Janssen B, Szende A. Population norms for the EQ-5D In: Szende A, Janssen B, Cabases J, editors. Self-reported population health: an international perspective based on EQ-5D. 1st ed. Dordrecht: Springer Dordrecht; (2014)</Citation><ArticleIdList><ArticleId IdType="pubmed">29787044</ArticleId></ArticleIdList></Reference><Reference><Citation>Eakin EG, Resnikoff PM, Prewitt LM, Ries AL, Kaplan RM. Validation of a new dyspnea measure: the UCSD shortness of breath questionnaire. Chest. (1998) 113:619&#x2013;24. doi: 10.1378/chest.113.3.619</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.113.3.619</ArticleId><ArticleId IdType="pubmed">9515834</ArticleId></ArticleIdList></Reference><Reference><Citation>Kupferberg DH, Kaplan RM, Slymen DJ, Ries AL. Minimal clinically important difference for the UCSD shortness of breath questionnaire. J Cardiopulm Rehabil. (2005) 25:370&#x2013;7. doi: 10.1097/00008483-200511000-00011</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00008483-200511000-00011</ArticleId><ArticleId IdType="pubmed">16327533</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroenke K, Spitzer RL, Williams JBW. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. (2001) 16:606&#x2013;13. doi: 10.1046/j.1525-1497.2001.016009606.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1525-1497.2001.016009606.x</ArticleId><ArticleId IdType="pmc">PMC1495268</ArticleId><ArticleId IdType="pubmed">11556941</ArticleId></ArticleIdList></Reference><Reference><Citation>Buysse D, Reynolds C, Monk T, Berman S, Kupfer D. The Pittsburgh sleep quality index: a new instrument for the psychiatric practice and research. Psychiatry Res. (1988) 28:193&#x2013;213. doi: 10.1016/0165-1781(89)90047-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0165-1781(89)90047-4</ArticleId><ArticleId IdType="pubmed">2748771</ArticleId></ArticleIdList></Reference><Reference><Citation>Rockwood K, Song X, MacKnight C, Bergman H, Hogan DB, McDowell I, et al. . A global clinical measure of fitness and frailty in elderly people. Can Med Assoc J. (2005) 173:489&#x2013;95. doi: 10.1503/cmaj.050051</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.050051</ArticleId><ArticleId IdType="pmc">PMC1188185</ArticleId><ArticleId IdType="pubmed">16129869</ArticleId></ArticleIdList></Reference><Reference><Citation>Karaarslan F, G&#xfc;neri FD, Karde&#x15f; S. Long COVID: rheumatologic/musculoskeletal symptoms in hospitalized COVID-19 survivors at 3 and 6 months. Clin Rheumatol. (2022) 41:289&#x2013;96. doi: 10.1007/s10067-021-05942-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-021-05942-x</ArticleId><ArticleId IdType="pmc">PMC8553494</ArticleId><ArticleId IdType="pubmed">34713356</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A, Nirantharakumar K, Hughes S, Myles P, Williams T, Gokhale KM, et al. . Symptoms and risk factors for long COVID in non-hospitalized adults. Nat Med. (2022) 28:1706&#x2013;14. doi: 10.1038/s41591-022-01909-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01909-w</ArticleId><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>Santis LVD, P&#xe9;rez-Camacho I, Sobrino B, Gonz&#xe1;lez GE, Ru&#xed;z-Mesa JD, Plata A, et al. . Clinical and immunoserological status 12 weeks after infection with COVID-19: prospective observational study. medRxiv. (2020). doi: 10.1101/2020.10.06.20206060v1</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.10.06.20206060v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Bansal R, Gubbi S, Koch CA. COVID-19 and chronic fatigue syndrome: an endocrine perspective. J Clin Transl Endocrinol. (2022) 27:100284. doi: 10.1016/j.jcte.2021.100284, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcte.2021.100284</ArticleId><ArticleId IdType="pmc">PMC8641402</ArticleId><ArticleId IdType="pubmed">34877261</ArticleId></ArticleIdList></Reference><Reference><Citation>Magnus P, Gunnes N, Tveito K, Bakken IJ, Ghaderi S, Stoltenberg C, et al. . Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is associated with pandemic influenza infection, but not with an adjuvanted pandemic influenza vaccine. Vaccine. (2015) 33:6173&#x2013;7. doi: 10.1016/j.vaccine.2015.10.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2015.10.018</ArticleId><ArticleId IdType="pubmed">26475444</ArticleId></ArticleIdList></Reference><Reference><Citation>Natelson BH, Brunjes DL, Mancini D. Chronic fatigue syndrome and cardiovascular disease JACC state-of-the-art review. J Am Coll Cardiol. (2021) 78:1056&#x2013;67. doi: 10.1016/j.jacc.2021.06.045</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2021.06.045</ArticleId><ArticleId IdType="pubmed">34474739</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravindran M, Adewuyi O, Zheng Y, Rayhan RU, Le U, Timbol C, et al. . Dyspnea in chronic fatigue syndrome (CFS): comparison of two prospective cross-sectional studies. Glob J Health Sci. (2013) 5:94&#x2013;110. doi: 10.5539/gjhs.v5n2p94</Citation><ArticleIdList><ArticleId IdType="doi">10.5539/gjhs.v5n2p94</ArticleId><ArticleId IdType="pmc">PMC4209305</ArticleId><ArticleId IdType="pubmed">23445698</ArticleId></ArticleIdList></Reference><Reference><Citation>Raj SR. Postural tachycardia syndrome (POTS). Circulation. (2013) 127:2336&#x2013;42. doi: 10.1161/CIRCULATIONAHA.112.144501, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.112.144501</ArticleId><ArticleId IdType="pmc">PMC3756553</ArticleId><ArticleId IdType="pubmed">23753844</ArticleId></ArticleIdList></Reference><Reference><Citation>Grover S, Sahoo S, Mishra E, Gill KS, Mehra A, Nehra R, et al. . Fatigue, perceived stigma, self-reported cognitive deficits and psychological morbidity in patients recovered from COVID-19 infection. Asian J Psychiatr. (2021) 64:102815. doi: 10.1016/j.ajp.2021.102815, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajp.2021.102815</ArticleId><ArticleId IdType="pmc">PMC8379818</ArticleId><ArticleId IdType="pubmed">34455354</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>